Compare ITRG & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITRG | PETS |
|---|---|---|
| Founded | 1997 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Retail-Drug Stores and Proprietary Stores |
| Sector | Basic Materials | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.5M | 63.7M |
| IPO Year | N/A | N/A |
| Metric | ITRG | PETS |
|---|---|---|
| Price | $4.47 | $3.48 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 2 | 1 |
| Target Price | ★ $4.13 | $3.20 |
| AVG Volume (30 Days) | 1.8M | ★ 7.7M |
| Earning Date | 11-12-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $219,125,000.00 | $198,265,000.00 |
| Revenue This Year | $1,016.77 | N/A |
| Revenue Next Year | $7.81 | $2.98 |
| P/E Ratio | $56.03 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.79 | $1.57 |
| 52 Week High | $4.69 | $5.58 |
| Indicator | ITRG | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 71.84 | 69.87 |
| Support Level | $4.01 | $3.42 |
| Resistance Level | $4.69 | $3.89 |
| Average True Range (ATR) | 0.24 | 0.39 |
| MACD | 0.03 | 0.17 |
| Stochastic Oscillator | 79.74 | 77.87 |
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.